FIELD: medicine.;SUBSTANCE: invention refers to gastroenterology. Antihelicobacter pharmacotherapy is combined with transcutaneous magnetic-laser therapy and magnetic-laser therapy at wave length 0.89 mcm with a magnetic beam 150 mTl, frequency 820 Hz with scaling to 80 Hz in erosions, and 360 Hz with scaling to 80 Hz in the absence of erosions. Scaling is carried out while pain syndrome is being relieved. Exposure covers epigastrium, celiac plexus, and duodenum projection. Magnetic-laser puncture is carried out by wave length 1.3 mcm, modulated mode, frequency 2.4 Hz, with a magnetic acupuncture beam 50 mTl. Exposure time is 10-30 s for a biologically active point. A point is chosen considering the state of vegetative balance.;EFFECT: allows normalising daily chronobiorhythm and the state of vegetative balance, reduces degree of manifestation of gastric mucosa pathology, extends remission time, and reduces recurrence rate.;3 cl, 1 tbl, 3 ex
展开▼